Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MIER3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | USF2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | KCNE3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | PPM1N | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | NEK2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | LRRC8E | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ANXA11 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | HECW1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | MAMDC4 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | PRSS37 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |